Valuation: Carvolix

Market Cap 36Cr 33Cr 30Cr 27Cr 51Cr 3.47TCr 52Cr 361.38Cr 143.94Cr 1.82TCr 136.73Cr 133.85Cr 5.76TCr P/E 2026 *
-12x
P/E 2027 * -12.1x
Enterprise Value 40Cr 36Cr 33Cr 30Cr 56Cr 3.8TCr 57Cr 396.1Cr 157.77Cr 1.99TCr 149.87Cr 146.71Cr 6.32TCr EV / Sales 2026 *
279x
EV / Sales 2027 * 11.6x
Free-Float
16.12%
Yield 2026 *
-
Yield 2027 * -
1 day+0.36%
1 week-3.82%
Current month-4.15%
1 month-1.77%
3 months-1.07%
6 months+87.80%
Current year+220.23%
1 week 5.36
Extreme 5.36
6.08
1 month 4.92
Extreme 4.92
6.08
Current year 1.73
Extreme 1.73
7.56
1 year 1.33
Extreme 1.33
7.56
3 years 1.16
Extreme 1.16
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap. Importance
24/10/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
27/09/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
06/02/24
Truffle Capital SAS
BuyCompany 14,19,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-3.82%+295.71%+346.77% 36Cr
-0.45%+2.12%-18.93%+10.37% 18TCr
+0.86%+2.15%-19.13%+15.77% 12TCr
+0.88%+1.88%+1.66%+35.46% 12TCr
-2.26%+18.07%-43.85%+5.76% 9.31TCr
-0.31%-4.72%-3.36%+74.94% 6.21TCr
+0.17%+1.64%+8.50%+82.24% 5.59TCr
+0.07%+0.42%+5.94%-22.27% 5.31TCr
+0.30%+1.70%-11.26%+42.01% 4.42TCr
+0.10%+3.37%-4.73%-8.71% 3.36TCr
Average +0.15%+1.63%+21.05%+58.23% 7.51TCr
Weighted average by Cap. +0.24%+2.37%-12.57%+24.01%

Financials

2026 *2027 *
Net sales 14.32L 12.85L 11.88L 10.76L 20.1L 14Cr 20.34L 1.42Cr 56.57L 7.14Cr 53.74L 52.6L 23Cr 3.74Cr 3.35Cr 3.1Cr 2.81Cr 5.24Cr 355.76Cr 5.31Cr 37Cr 15Cr 186.16Cr 14Cr 14Cr 591Cr
Net income -3.76Cr -3.37Cr -3.12Cr -2.82Cr -5.28Cr -357.99Cr -5.34Cr -37Cr -15Cr -187.33Cr -14Cr -14Cr -594.69Cr -1.15Cr -1.04Cr -95.73L -86.7L -1.62Cr -109.92Cr -1.64Cr -11Cr -4.56Cr -58Cr -4.33Cr -4.24Cr -182.6Cr
Net Debt 3.5Cr 3.14Cr 2.9Cr 2.63Cr 4.91Cr 333.47Cr 4.97Cr 35Cr 14Cr 174.5Cr 13Cr 13Cr 553.97Cr 6.9Cr 6.19Cr 5.72Cr 5.18Cr 9.68Cr 657.03Cr 9.8Cr 68Cr 27Cr 343.81Cr 26Cr 25Cr 1.09TCr
Projected Income Statement - Annual - Carvolix
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
102
Date Price Change Volume
28/26/28 €5.540 +0.36% 13,245
27/26/27 €5.520 -6.12% 40,218
26/26/26 €5.880 +1.73% 29,181
23/26/23 €5.780 -2.69% 6,634
22/26/22 €5.940 +0.34% 15,136
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Carvolix
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.520EUR
Average target price
8.775EUR
Spread / Average Target
+58.97%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Carvolix